Trilogy Capital’s iShares Morningstar Mid-Cap Growth ETF IMCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355K Sell
3,614
-38
-1% -$3.43K 0.01% 312
2026
Q1
$288K Sell
3,652
-836
-19% -$68.5K 0.01% 330
2025
Q4
$358K Sell
4,488
-3,191
-42% -$259K 0.02% 291
2025
Q3
$635K Buy
7,679
+754
+11% +$61.5K 0.03% 227
2025
Q2
$556K Buy
+6,925
New +$515K 0.03% 223

Other funds holding IMCG

Trilogy Capital's IMCG Position: Q2 2026 in Review

Trilogy Capital reduced its iShares Morningstar Mid-Cap Growth ETF (IMCG) stake by 1% in Q2 2026, selling an estimated $3.43K and leaving 3,614 shares worth $355K. The position accounts for 0.01% of the portfolio, ranked #312.

Trilogy Capital first reported a position in IMCG in Q2 2025 and has held it in 5 quarters since. The position peaked at $635K in Q3 2025. 423 funds tracked by Wall St. Rank hold IMCG as of Q2 2026.

  • Trilogy Capital held 3,614 shares of iShares Morningstar Mid-Cap Growth ETF worth $355K as of Q2 2026.
  • Trilogy Capital sold 38 iShares Morningstar Mid-Cap Growth ETF shares in Q2 2026, an estimated $3.43K.
  • iShares Morningstar Mid-Cap Growth ETF made up 0.01% of Trilogy Capital's portfolio in Q2 2026, its #312 holding.
  • Trilogy Capital first reported a position in iShares Morningstar Mid-Cap Growth ETF in Q2 2025 and has held it in 5 quarters since.
  • Trilogy Capital's iShares Morningstar Mid-Cap Growth ETF position peaked at $635K in Q3 2025.
  • 423 funds tracked by Wall St. Rank held iShares Morningstar Mid-Cap Growth ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.